Capricor Therapeutics, Inc.
CAPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133869
No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.
Holders of 5% or more of CAPR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Capricor Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 6.50%2.97M shares | – | Feb 5, 20251 filing | Feb 5, 2025 | SEC |
| Vanguard Group Inc | 13G | 5.04%2.31M shares | +0.09 ppfrom 4.95% | Jan 30, 20253 filings | Jul 29, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Capricor Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 29, 202511:23 AM ET | Vanguard Group Inc | 13G | 5.04%2.31M shares | +0.09 ppfrom 4.95% | Jun 30, 2025 | SEC |
| Apr 30, 202510:58 AM ET | Vanguard Group Inc | 13G/A | 4.95%2.26M shares | −0.05 ppfrom 5.00%Below 5% | Mar 31, 2025 | SEC |
| Feb 5, 20255:28 PM ET | BlackRock, Inc. | 13G/A | 6.50%2.97M shares | – | Dec 31, 2024 | SEC |
| Jan 30, 20259:34 PM ET | Vanguard Group Inc | 13G | 5.00%2.28M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Capricor Therapeutics, Inc. shares.
No Form 144 notices for Capricor Therapeutics, Inc. are on file.